Adaptive Biotechnologies
ADPT
$22.57
-6.66%
ADPT price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Adaptive Biotechnologies's 12-month outlook, with a consensus price target around $23.86 and implied upside of +5.7% versus the current price.
Average Target
$23.86
0 analysts
Implied Upside
+5.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$20 - $28
Analyst target range
ADPT Technical Analysis
Beta
2.07
2.07x market volatility
Max Drawdown
-39.4%
Largest decline past year
52-Week Range
$10-$25
Price range past year
Annual Return
+120.4%
Cumulative gain past year
| Period | ADPT Return | S&P 500 |
|---|---|---|
| 1m | +0.9% | +0.2% |
| 3m | +58.2% | +3.7% |
| 6m | +22.0% | +8.0% |
| 1y | +120.4% | +18.2% |
| ytd | +41.9% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is ADPT Overvalued?
PE
-41.6x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-89.6x
Enterprise Value Multiple